Note: PLOS issued the following press release on Monday, August 26, 2024 SAN FRANCISCO — The University of South Carolina and the…
PLOS Authors Say “Yes” to Preprints
We’ve surpassed 1,300 preprint posts to bioRxiv!
This is an incredible milestone for us and for all of our authors who chose to opt-in to our preprint service since we announced our partnership with Cold Spring Harbor Laboratory’s bioRxiv six months ago. We wanted to bring an easy preprint-posting option directly to the submission process for our authors and are thoroughly excited with the results we’ve seen so far.
The road to preprints
As we began this journey, about 4% of our authors reported that they had posted their submission to a preprint server. While this base remains consistent, our preprint-posting service has built upon it to offer authors more choices. In the past six months we’ve seen an additional 14% opt-in to have PLOS post a preprint on their behalf, indicating that 18% of our authors want to use preprints to share their research.
Of course, the opt-in rate varies by discipline. On PLOS Computational Biology 46% of our authors choose to make a preprint of their manuscript available, with half of those posting before submission and the other half requesting PLOS post to bioRxiv on their behalf. In biology in general, the adoption is high. PLOS Biology, which joined the service later, is already showing a promising trend towards preprints by 39% of our authors (23% of which elect to have PLOS post on their behalf).
Every opt-in we get is screened by editorial staff before posting to ensure the article fits bioRxiv’s scope and that no sensitive information is accidentally shared. We have also taken a conservative approach and avoided posting research that could have an impact on human health before the claims have been peer reviewed, which is why we do not yet offer to post preprints for PLOS Medicine authors. We’re working in partnership with bioRxiv to refine the posting criteria as we learn more about the needs for early sharing in different communities.
Overall, the openness to new research outputs we’ve seen among our community of authors is inspiring and we hope to see preprint adoption grow even more over the coming year.
Author choice
We like preprints because they put your research first. We’re making it easier for you to choose preprints as a way to rapidly disseminate your research results, establish priority, accumulate citations for your work, and receive input from your community that may help shape the future of your research.
That said, preprints aren’t for everyone or for every paper which is why authors choose when and how their work becomes available. We’re also listening to our community’s feedback to make our service as inclusive as possible.
Many of our authors still prefer to wait for peer review before making their results public. However, about a fifth of the authors who responded to a survey about why they had opted out said they are unfamiliar with preprints. We’re hoping to change that by offering everything you need to know at staging.plos.org/preprints. More information about preprints is available on bioRxiv along with their posting guidelines. ASAPbio also offers very useful guidance for preprints, including preprint policy at other journals which may help clarify any concerns you have about submitting a manuscript after you’ve posted a preprint.
Where we go from here
We’ll continue learning from our community and sharing more information that helps you make the right decision for your paper. We’re also encouraging other preprint options to authors in areas that don’t fall under bioRxiv’s scope. Both PLOS Genetics and PLOS ONE have dedicated Preprint Editors to solicit submissions from various preprint servers and we’re looking at more opportunities.
If you’re thinking of posting a preprint for the first time, take advantage of this checklist to get started and review all the benefits preprints could have for your work.